UBS AM’s Aehr Test Systems AEHR Stock Holding History

UBS AM’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Buy	34,381 +5,379	+19%	+$172K	﹤0.01%	2241
2025 Q4	$586K	Buy	+29,002	New	+$701K	﹤0.01%	2291
2024 Q2	–	Sell	-33,566	Closed	-$416K	–	2798
2024 Q1	$416K	Hold	33,566	–	–	﹤0.01%	2337
2023 Q4	$891K	Sell	33,566 -324	-1%	-$9.45K	﹤0.01%	2097
2023 Q3	$1.55M	Buy	33,890 +27,190	+406%	+$1.26M	﹤0.01%	1739
2023 Q2	$208K	Hold	6,700	–	–	﹤0.01%	2564
2023 Q1	$208K	Sell	6,700 -4,700	-41%	-$151K	﹤0.01%	2564
2022 Q4	$229K	Buy	+11,400	New	+$244K	﹤0.01%	2410

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM's AEHR Position: Q1 2026 in Review

UBS AM increased its Aehr Test Systems (AEHR) stake by 19% in Q1 2026, buying an estimated $172K and bringing the position to 34,381 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

UBS AM first reported a position in AEHR in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.55M in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

UBS AM held 34,381 shares of Aehr Test Systems worth $1.27M as of Q1 2026.
UBS AM bought 5,379 Aehr Test Systems shares in Q1 2026, an estimated $172K.
Aehr Test Systems made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2241 holding.
UBS AM first reported a position in Aehr Test Systems in Q4 2022 and has held it in 8 quarters since.
UBS AM's Aehr Test Systems position peaked at $1.55M in Q3 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.